Bacterial Disease Diagnostics Market Size

  • Report ID: 5206
  • Published Date: Aug 02, 2024
  • Report Format: PDF, PPT

Bacterial Disease Diagnostics Market Size

Bacterial Disease Diagnostics Market size was valued at USD 3.23 Billion in 2023 and is set to cross USD 8.59 Billion by the end of 2036, expanding at more than 7.8% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of bacterial disease diagnostics is estimated at USD 3.46 Billion. The growth of the market can be attributed to the growing incidences of mass food poisoning. In the world, around 600 million fell ill due to the consumption of contaminated food and nearly 33 million lost their lives. Bacterial illness is a leading cause of food poisoning in humans. As consumers become increasingly worried about food safety, the demand for trustworthy bacterial illness diagnostics grows.

In addition to this, one aspect that is expected to drive the growth of the bacterial disease diagnostics market is rising research on new treatments and diagnoses. BARDA has collaborated with the government to help a number of companies research novel infectious disease medications. Ongoing research aids in the identification and description of new bacterial pathogens. Researchers can aid in the development of diagnostic tests for these novel infections, aiding disease control.


Bacterial Disease Diagnostics Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5206
  • Published Date: Aug 02, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of bacterial disease diagnostics is estimated at USD 3.46 Billion.

The bacterial disease diagnostics market size was valued at USD 3.23 Billion in 2023 and is set to cross USD 8.59 Billion by the end of 2036, expanding at more than 7.8% CAGR during the forecast period i.e., between 2024-2036. Increasing cases of bacterial infection and technological advancement in diagnostic technology are the major factors driving the market growth.

North America industry is projected to be the largest with a share of about 35% by 2036, due to rising instances of fatal infections caused by bacteria in the region.

bioMérieux SA, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company, DiaSorin SpA (Luminex), Accelerate Diagnostics Inc., Bruker Corp., Danaher Corp., Torus Biosystems, GENERI BIOTECH s.r.o.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample